Cargando…
Long-Term Effects of Suramin on Renal Function in Streptozotocin-Induced Diabetes in Rats
In short-term diabetes (3 weeks), suramin, a drug used clinically, affects renal function and the expression of vascular endothelial growth factor A (VEGF-A), which may be involved in the pathogenesis of diabetic nephropathy, the main cause of end-stage renal disease. In the present study, we evalua...
Autores principales: | Chyła-Danił, Gabriela, Sałaga-Zaleska, Kornelia, Kreft, Ewelina, Stumski, Olaf, Krzesińska, Aleksandra, Sakowicz-Burkiewicz, Monika, Kuchta, Agnieszka, Jankowski, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572378/ https://www.ncbi.nlm.nih.gov/pubmed/37834118 http://dx.doi.org/10.3390/ijms241914671 |
Ejemplares similares
-
Suramin Affects the Renal VEGF-A/VEGFR Axis in Short-Term Streptozotocin-Induced Diabetes
por: Chyła-Danił, Gabriela, et al.
Publicado: (2023) -
Suramin enhances the urinary excretion of VEGF-A in normoglycemic and streptozotocin-induced diabetic rats
por: Chyła, Gabriela, et al.
Publicado: (2021) -
Redox regulation of hemodynamics response to diadenosine tetraphosphate an agonist of P2 receptors and renal function in diet‐induced hypercholesterolemic rats
por: Dąbkowski, Kamil, et al.
Publicado: (2021) -
Lipid Profile, Lp(a) Levels, and HDL Quality in Adolescents with Down Syndrome
por: Krzesińska, Aleksandra, et al.
Publicado: (2022) -
Nanoparticle Tracking Analysis of Urinary Extracellular Vesicle Proteins as a New Challenge in Laboratory Medicine
por: Sałaga-Zaleska, Kornelia, et al.
Publicado: (2023)